key: cord-0954969-0xasl6vs
authors: Aydemir, Merve Nur; Aydemir, Habes Bilal; Korkmaz, Ertan Mahir; Budak, Mahir; Cekin, Nilgun; Pinarbasi, Ergun
title: Computationally predicted SARS-COV-2 encoded microRNAs target NFKB, JAK/STAT and TGFB signaling pathways
date: 2020-12-31
journal: Gene Rep
DOI: 10.1016/j.genrep.2020.101012
sha: 2813726eb1d791edd6d91f872e6b2c3602d4289d
doc_id: 954969
cord_uid: 0xasl6vs

Recently an outbreak that emerged in Wuhan, China in December 2019, spread to the whole world in a short time and killed >1,410,000 people. It was determined that a new type of beta coronavirus called severe acute respiratory disease coronavirus type 2 (SARS-CoV-2) was causative agent of this outbreak and the disease caused by the virus was named as coronavirus disease 19 (COVID19). Despite the information obtained from the viral genome structure, many aspects of the virus-host interactions during infection is still unknown. In this study we aimed to identify SARS-CoV-2 encoded microRNAs and their cellular targets. We applied a computational method to predict miRNAs encoded by SARS-CoV-2 along with their putative targets in humans. Targets of predicted miRNAs were clustered into groups based on their biological processes, molecular function, and cellular compartments using GO and PANTHER. By using KEGG pathway enrichment analysis top pathways were identified. Finally, we have constructed an integrative pathway network analysis with target genes. We identified 40 SARS-CoV-2 miRNAs and their regulated targets. Our analysis showed that targeted genes including NFKB1, NFKBIE, JAK1–2, STAT3–4, STAT5B, STAT6, SOCS1–6, IL2, IL8, IL10, IL17, TGFBR1–2, SMAD2–4, HDAC1–6 and JARID1A-C, JARID2 play important roles in NFKB, JAK/STAT and TGFB signaling pathways as well as cells' epigenetic regulation pathways. Our results may help to understand virus-host interaction and the role of viral miRNAs during SARS-CoV-2 infection. As there is no current drug and effective treatment available for COVID19, it may also help to develop new treatment strategies.

miRNAs during SARS-CoV-2 infection. As there is no current drug and effective treatment available for COVID19, it may also help to develop new treatment strategies.

The outbreak that emerged in Wuhan, China in December 2019, spread to the whole world in a short time. It was determined that a new type of beta coronavirus called severe acute respiratory disease coronavirus type 2 (SARS-CoV-2) was causative agent of this outbreak . The disease caused by the virus was named coronavirus disease 19 by International Committee on Taxonomy of Viruses (ICTV) as its similarity to the one that caused the SARS outbreak (SARS-CoVs). Later, it was declared as a pandemic in March 2020 by World Health Organization (WHO). COVID-19 spreads all over the world except Antarctica in four months and transmitted to >60 million people and killed over 1,410,000 people. COVID-19 is mainly transmitted between people through "respiratory droplets" when symptomatic people sneeze or cough (Huang et al., 2020; Li et al., 2020) . The disease starts as an acute pneumonia in most of the patients with clinical symptoms including fever, cough, myalgia and fatigue. In severe forms of the disease most patients develop and die. The cytokine storm was reported to be associated with disease severity (Guo et al., 2020; Huang et al., 2020) .

SARS-CoV-2 is a positive-stranded RNA virus belongs to Coronaviridae family. Its single-stranded RNA genome contains 29,891 nucleotides with a 5 ′ -cap structure and 3 ′ -poly-A tail, encoding for 9860 amino acids. Its genome shows 89% nucleotide identity with bat SARS-like-CoVZXC21 and 79.2% with that of human SARS-CoV (Chan et al., 2020; Lu et al., 2020) . Sequence analysis of SARS-CoV-2 revealed that ORF1ab located in the first part of the viral genome translates polyproteins pp1a and pp1ab that responsible for encoding 16 nonstructural proteins (NSP). The remaining virus genome encodes several accessory proteins and four major structural proteins the spike (S) protein, nucleocapsid (N) protein, membrane (M) protein, and the envelope (E) protein. The S protein is responsible for facilitating entry of the CoV into the target cells. To infect humans it binds to Angiotensin-Converting Enzyme 2 (ACE-2) and enters cells (P. Zhou et al., 2020) .

Despite the information obtained from the viral genome structure, many aspects of virus-host interactions are still unknown during infection. In recent years, the relationship has been reported between small RNA molecule pathways, especially microRNA (miRNA) pathways, and diseases including cancer, cardiovascular disease, neurodegenerative disease and diseases caused by viruses and bacteria (Backes et al., 2012; Femminella et al., 2015; Ha, 2011; Jopling, 2005; Qi et al., 2016) . miRNAs are ~19-24 nt non-coding RNA molecules that posttranscriptionally regulate gene expression by binding to target messenger RNAs (mRNAs) (Bartel, 2009) . First identified in Caenorhabditis elegans, miRNAs are expressed by all metazoans and plants, as well as by several DNA and RNA viruses, and function as regulators of cellular processes such as development, differentiation, growth, homeostasis, stress responses, apoptosis and immune activation (Beckham and Parker, 2008; Friedman et al., 2009; Skalsky and Cullen, 2010; Xiao and Rajewsky, 2009) .

Results obtained in the studies conducted after 2003 SARS and 2014 Ebola virus outbreaks showed that viral small non-coding RNA molecules are involved in pathogenesis of the disease (Morales et al., 2017; Prasad et al., 2019; Teng et al., 2015) . Discovering these RNA molecules may help to understand virus-host interactions during infection that could speed up effective treatment of SARS-CoV-2 caused COVID-19. In this study bioinformatics-driven prediction tools were used to find the presence of putative miRNAs encoding by SARS-CoV-2 genome. The identified 40 different putative miRNAs encoded from different regions of SARS-Cov-2 viral RNA genome were found to be targeting different human genes involved in host biological processes such as apoptosis, immune system, cell cycle and regulation of transcription signaling pathways. Our results may help to understand virus-host interaction and the role of viral miRNAs during SARS-CoV-2 infection. As there is no current drug and effective treatment available for COVID-19, it may also help to develop new treatment strategies.

We retrieved full SARS-CoV-2 viral genome with NC_045512 accession number from the genome browser at NCBI Database.

A flowchart describing the computational prediction of the putative SARS-CoV-2 miRNAs is shown in Fig. 1 .

Precursor miRNA (pre-miRNA) candidates assumed to be encoded from the viral genome were predicted by the VMir program (Grundhoff et al., 2006) . This program identifies possible stem-loop structures using the RNAFold database. VMir predictions were carried out using the default parameters. The putative pre-miRNAs that satisfied the filter parameters of a VMir score ≥ 150 and a window count ≥35 and stringency = 30 were selected for further assessment. Then, MiPred analysis was carried out in the R package program to remove pseudo miRNAs from the obtained sequences to identify candidates with appropriate secondary structure folds and free energy values (Jiang et al., 2007) . MatureBayes program was used settings to obtain mature 3 ′ and 5 ′ stem sequences from pre-miRNA sequences, with default settings (Gkirtzou et al., 2010) . The BLASTn option in the miRBase database was used to investigate the similarity of identified mature viral miRNAs to previously identified human miRNAs (Griffiths-Jones et al., 2008) . To provide a more accurate estimate, the secondary and tertiary structures of each candidate pre-miRNA sequences were determined using RNAFold program in Vienna format (dot-bracket) and then visualized using the VARNA program (Darty et al., 2009) . Finally, the tertiary structures of candidate premiRNAs were visualized by the RNA FRABASE database (Popenda et al., 2010) .

Human target genes of novel the SARS-CoV-2 miRNAs were investigating using three miRNA prediction methods: TargetScanHuman 7.2 custom with using miRNAs' 7-mer seed regions; miRDB custom with target score ≥ 95 option and miRanda 3.0 with Score Threshold≥140 filter option (Agarwal et al., 2015; Enright et al., 2003; Wong and Wang, 2015) . The common target genes, which are obtained from these three programs, were used for subsequent KEGG and GO analysis.

We used KEGG (Kyoto Encyclopedia of Genes and Genomes) a database resource that integrates genomic, chemical and systemic functional information, for pathway analysis (Kanehisa, 2000) . The PATHWAY database records networks of molecular interactions in the cell that includes organism-specific network maps (http://www.genome .jp/kegg/). Integration map of target genes were drawn using Networ-kAnalyst program (G. Zhou et al., 2019) .

Target genes with an interaction value of over 80 were filtered and used in GO and PANTHER analyzes (Ashburner et al., 2000; Carbon et al., 2019; Mi et al., 2019) . GO analysis of the significant probe list was performed using PANTHER (http://www.pantherdb.org/) text files containing the Gene ID list.

SARS-CoV-2 genome with the accession number of NC_045512 was used as a reference genome. Using VMir default parameters, we identified 1114 candidate precursor miRNA (Pre-miRNA) sequences between 50 and 220 nucleotides in length. When pseudo-pre-miRNA sequences were removed, 20 real pre-miRNA candidates were found in MiPred analysis. Sequence of each pre-miRNAs, their secondary structure in Vienna format and MFE values are given in Table 1 .

MatureBayes tool was used to predict mature pre-miRNAs from the pre-miRNA stem loops and 40 mature miRNAs were identified and named as SARS-CoV-2 pre-miR-5p for forward and SARS-CoV-2 pre-miR-3p for reverse orientation ( Table 2 ). Position of each SARS-CoV-2 pre-miRNA, their orientation and minimum free energy values (MFE) with forward or reverse orientation are shown on the genome of the virus (Fig. 2) . Out of 20 pre-miRNAs 14 pre-miRNAs were encoded from viral orf1ab gene (SARS-CoV-2 pre-miR-D1 and pre-miR-D2 were from nsp2; SARS-CoV-2-pre-miR-D3, pre-miR-D4, pre-miR-D5, pre-miR-R1, and pre-miR-R2 were form nsp3; SARS-CoV-2-pre-miR-D6 was from nsp4; SARS-CoV-2-pre-miR-D7 and pre-miR-D8 were from nsp6; SARS-CoV-2-pre-miR-R3 was from RdRP; SARS-CoV-2-pre-miR-D9 was from exonuclease; SARS-CoV-2-pre-miR-D10 from EndoRNase; SARS-CoV-2pre-miR-D11 was from ribose methlytransferase). Three miRNAs were encoded from M gene (SARS-CoV-2-pre-miR-D12, and pre-miR-D13, pre-miR-R5). SARS-CoV-2-pre-miR-R4, pre-miR-D14 and pre-miR-R6 were encoded from orf3a, orf7a/b and orf10 respectively.

The BLASTn option was used in the miRBase database to investigate whether each mature SARS-CoV-2 premiRNA sequence shows any similarity to previously identified miRNAs. We found that the SARS-CoV-2-D1-5p, D4-3p, R3-3p and R6-5p pre-miRNAs exhibit similarity to human hsa-miR-4696-3p, hsa-miR-4502, hsa-miR-363-5p and hsa-miR-411-5p, respectively.

RNA fold prediction was used to verify the secondary and tertiary structures of each SARS-CoV-2 pre-miRNA. Folds of these pre-miRNAs, along with their flanking sequences, into the expected hairpin structures were successful in all candidates. The MFE value of each stable stem loop secondary structure varies between − 15.6 and − 42.10 ( Table 1 ). The secondary structures of each pre-miRNA sequence visualized with the VARNA program and the tertiary structures obtained computationally are given in Fig. 3 . The positions of possible mature miRNAs were colored in secondary and tertiary structures (Fig. 3) .

Based on the sequences of the 40 SARS-CoV-2 miRNAs, their target genes were searched by TargetScan and miRDB under custom prediction and miRanda with filtering option. In total 5615, 1235 and 265 human genes were targeted by 40 SARS-CoV-2 miRNAs with TargetScan, miRDB and miRanda programs, respectively. The results of the all target genes according to of each miRNA are given in Table S1 . Sequences with network interaction scores <80 were removed and the high probability targets of each miRNA, determined by TargetScan, miRDB and miRanda programs, were used in further analysis.

Identified proteins were clustered into groups according to their biological process, molecular function, protein class, cellular compartment and signaling pathways using GO and PANTHER analysis. With such a grouping, multiple functions and protein interaction networks of a protein can be revealed. Biological process group included proteins involved in cellular process (22.10%), biological regulation (15%) and metabolic process (15.30%) (Fig. 4a ). The cellular compartment group included proteins located in cell (23.80%), cell part (23.80%) and organelles (16.90%) (Fig. 4b ). Molecular function group comprised proteins with binding (41.90%), catalytic activity (34.70%), and transcription regulator activity (9%) (Fig. 4c ). Protein Class group included proteins with protein modifying enzyme (24.5%), gene specific transcriptional regulator (15.1%) and protein-binding activity modulator (13.2%) (Fig. 4d) .

Our KEGG analysis revealed that while 89 different clusters are formed in terms of pathways, 31 of them are represented below 1%. The top represented pathways were 5.10% Gonadotropin-releasing hormone receptor (P06664), 5.10% Angiogenesis (P00005), 5.00% CCKR signaling map (P06959), 4.40% EGF receptor signaling pathway (P00018), 4.10% Inflammation mediated by chemokine and cytokine signaling (P00031), 3.20% T cell activation (P00053), 3.50% PDGF signaling (P06959) P00047) and 2.70% Interleukin signaling pathway (P00036) (Fig. 4e) . These pathways are all important for host-virus interactions.

KEGG pathway enrichment annotations were also carried out using the NetworkAnalyst program in order to obtain target gene interaction map. Potential target genes involve in negative regulation of apoptotic processes, viral processes, protein phosphorylation and regulation of cell cycle (Fig. 5 ).

Workflow of SARS-CoV2 encoded miRNA prediction. Flowchart describes the computational prediction steps. The MiPred algorithm was used to identify genuine pre-miRNAs, and the MatureBayes tool was used to predict the mature miRNA sequences. ((((((((.(((((((((.((((((((((((.(((…((……) ) …)))..)))))))….))))))))))))))…..)))))))) − 29,00 29,532-29,625 gene N (structural nucleocapsid phosphoprotein) + ORF10 ((((((.(((((((((((..((( …....((((.(((((.. .)))))))))))).)))))))...)))).))..))))))

− 16,20 27,167-27,246 gene M+ ORF6 80 120.7 ((.(((…...(((((((((((((((....(((((.(((((.. .))))). ))))).)))))..))))))))))))))))) (((..((((..((((((..((((((((((..((((((.(((( …...((((((.. ..))))))))))))))))....)).)))))))).))))))......))))...))) ((((((.((.(((.(((…...(((((.((((((....(((((((.(((.((((... ..)))).))).))).)))).))))))..)))))))).))).))..)))))) ((((((((.((((.(((.(((((((…...((.((((((... ...))).))).)).))))))).)))......))))..)))))))))) ((((((((….....(((.(((....((((((((.(((.((.(((((. ((((((.. .))))))))))).)).. ..))))))))))).))).))))))))))))) .......))))))))))....)))))))))))))))))))))))......)))))) ((.(((((((((..(((..((.((((((((((..(((.(((... ..))))))))))).))))).)).)))..))))))).)).)) ((((((.(((.(((..((((((((((((((((((((((((..(((..(((((.. .)))))))))))))))).))).)))))))).)))))…...)))....))).)))))) ((..((((((((((.(((((.(((((.. ...)) …...))).)))))))))))).)))..))

− 15,60 20,452-20,511 ORF1ab-endoRNase 60 120.6 (((((...((((((((.((((.(((.(((((.. ...))))).))))))).)))))))).))))))) (((((((((((.((((.(((((((... ...))).)))).))))))))))).))))))....))))) ((((..(((.((((((((((.(((((((((((.....(((((...(((((.. ...))))). ...)))))…...))))))))))))))))))))).))))))) (((.((((((((.....(((((((..((((((...(((((((..(((((((((.((.(((.. ..))).)))))))))))....))))))).....))))))))))))).....))))…...)))).))) 

In order to narrate gene targets of SARS-CoV-2 miRNAs, we further filtered the genes according to cytotoxin and gene regulation-association using PANTHER analysis. Main gene targets are shown in Table 3 .

Our analysis showed that proteins that have critical roles in NFKB, JAK/STAT and TGFB pathways were targets of SARS-CoV-2 miRNAs. In addition, epigenetic factors such as JARIDs and HDACs are targeted by SARS-CoV-2 miRNAs. Tumor suppressor genes including RB1, PTEN, AKT1, CTNNB1 and different serine threonine and tyrosine kinases are among the viral miRNA targets.

The COVID-19 outbreak caused by SARS-CoV-2, which started in December 2019 in Wuhan, China, spread all over the world. >60 million people were infected and >1,410,000 people were killed to date (Valencia, 2020; Wu et al., 2020) . The epidemic declared as a pandemic continues to threaten the whole world. Despite the intensive studies of the scientific world, an effective treatment against the disease has not been developed yet. Although SARS-CoV-2 transmission method, entry into cells, and genome structure were determined, virus-host interaction is still unknown.

Viruses, despite their small genomes, have evolved to use the cellular mechanisms of the host they infect (Domingo and Perales, 2019; Holmes, 2009 ). Most DNA viruses encode miRNAs to hijack vital cellular functions of hosts to maintain viral pathogenesis, but RNA-virus encoded miRNAs remain controversial. Several miRNAs have been experimentally identified including West Nile virus (WNV), Dengue virus (DENV), hepatitis A virus (HAV) and Ebola virus. Additionally viral miRNAs in numerous viruses have been identified using computational prediction followed by experimental validation (Hussain and Asgari, 2014; Hussain et al., 2012; Liang et al., 2014) .

Here, we applied a computational method to predict miRNAs encoded by SARS-CoV-2 along with their putative targets in humans. Targets of predicted miRNAs were clustered into groups according to their biological processes, molecular function, and cellular compartments using GO and PANTHER databases. By using KEGG pathway enrichment analysis top pathways were identified. Finally, we have constructed an integrative pathway network analysis with target genes.

The computational method used in this study was very similar to one applied previously to predict Ebola virus miRNAs (Liang et al., 2014) . We identified 40 mature miRNAs encoded from SARS-CoV-2-genome. Considering the results, we obtained, it was seen that SARS-COV-2 miRNAs, targeted many human genes with different functions as expected.

miRNAs are potentially ideal tools for viruses to modulate gene expression because a single miRNA could modulate many genes. They act to achieve latent and lytic life cycle balance for persistence of virus, immune evasion, prevention of apoptosis, viral replication regulation and host cell cycle regulation (Takane and Kanai, 2011) .

Our target gene analysis showed that the identified 40 SARS-CoV-2 miRNAs target genes in signaling pathways including NFKB, JAK/ STAT and TGFB signaling pathways. All of these pathways are vital for the cell to be protected from viral infections. The NFKB pathway is often targeted by viral pathogens to enhance viral replication, host cell survival and host immune evasion. Viruses may activate or suppress NFKB (Santoro et al., 2003) . In our study NFKB1 and NFKBIE genes were targeted by SARS-COV-2 miRNAs; SARS-CoV-mir-D8-5p, SARS-CoVmir-R1-5p respectively. The NFKB1 gene encodes the protein p105, which can undergo proteosomal processing to p50. The protein p50 most commonly binds to p65 and together constitute the classic canonical NFKB heterodimer that drives expression of pro-inflammatory genes (Schmitz et al., 2014) . NFKBIE encodes Iκ B epsilon (Iκ Bε) and it inhibits NFKB by complexing with and trapping it in the cytoplasm (Rahman and McFadden, 2011) . Another gene in this pathway targeted ((((.....) )).))))))) …...))).))))).....))))))))))) ..)))))))).)))))))))))).))..)))))) .(((....) ))..)))))))).))))))…... )))))))))).))))))..)))))))))))..)))) ....) )))))))))).))).

..)))))).))).)))))))...)))..))))) ...) ).))))))).))).)))).))))))..))) (Canton et al., 2018) . Treatment with drugs that inhibited NFKB activation led to a reduction in inflammation and lung pathology in both SARS-CoV-infected cultured cells and mice and significantly increased mouse survival after SARS-CoV infection (Vitiello et al., 2012) . So, the role of NFKB1 and NFKBIE targeted by SARS-CoV2 miRNAs can be studied as a potential therapeutic target in COVID-19 (Vitiello et al., 2012) , as there are >700 NFKB inhibitors described (Gilmore and Herscovitch, 2006) . CXCL proteins are pro-inflammatory proteins induced during viral infections. CXCL9 and CXCL10 stimulate the activation and migration of immune cells to the infected sites, especially activated T cells. Previous studies with human immunodeficiency virus (HIV), human cytomegalovirus, hepatitis C virus (HCV) and avian H5N1 and human pdmH1N1 and H3N2 viruses showed that CXCL8, CXCL9, and CXCL10 are associated with pathogenicity and may serve as clinical indicator for clinical disease severity and progression and antiviral therapy outcome (Betakova et al., 2017; Stacey et al., 2009) . In our study, CXCL1, CXCL9, CXCL10, CXCL11 and CXCL16 were targeted by 6 different SARS-CoV-2 miRNAs (Table 3) . Analysis the level of these proteins in COVID-19 patients may help to understand the severity of the disease.

JAK-STAT pathway is another important pathway for cells to fight against viral infections. As this pathway is an important regulator of host immune responses against invading viruses, it has been the target of many viral proteins (Shuai and Liu, 2003) . It has also been implicated in many autoimmune diseases (Salas et al., 2020) . Therefore, the JAK/ STAT pathway should work effectively, when the immune system is activated, and the effect of this pathway should be reduced when the The binding of cytokines, such as interferons and interleukins, causes activation of JAKs which in turn activate STATS. These activated STATs form hetero-or homodimers, then translocate to the cell nucleus to induce transcription of target genes including immune response genes (Harrison, 2012) . In our study JAK1 and JAK2 and STAT3, STAT4, STAT5B and STAT6 were targeted by SARS-CoV-2 miRNAs (Table 3) . This pathway has been targets for the majority of viruses including coronaviruses, SARS-CoV and MERS-CoV. In addition, many viruses target more than one factor in this pathway (Fleming, 2016; Kuchipudi, 2015; Laurent-Rolle et al., 2010; Parisien et al., 2001; Simmons et al., 2010) . In some cases, the virus induces the upregulation of suppressor of cytokine signaling cellular genes (SOCS) that regulate this pathway (Starr et al., 1997) . Indeed, in our study SARS-CoV-2 miRNAs SARS-CoV-mir-D6-3p, SARS-CoV-mir-D8-5p, SARS-CoV-mir-D10-5p, SARS-CoV-2-mir-D5-3p, SARS-CoV-2-mir-D11-5p, SARS-CoV-2-mir-D14-3p, SARS-CoV-2-mir-D6-3p, SARS-CoV-2-mir-D8-5p, SARS-CoV-2-mir-D2-3p, SARS-CoV-2-mir-D14-5p, SARS-CoV-mir-D6-5p, SARS-CoV-mir-R3-3p, SARS-CoV-mir-R5-5p targeted SOCS1-6 genes. It seems that in order to control this pathway SARS CoV2 targets many proteins in this pathway with miRNAs encoded from its genome. The transforming growth factor beta (TGFB) signaling pathway is involved in many cellular processes including cell survival, apoptosis and immunity. Although TGFB pathway has important roles in many cellular processes, it is often manipulated by viruses as it is a simple pathway. In our study, proteins that play crucial role in almost every step of this pathway are targeted by SARS-CoV-2 miRNAs. TGFBR1 and TGFBR2, SMAD2, SMAD3 and SMAD4 were all found to be targeted by SARS-CoV-2 miRNAs (Table 3) . SARS-CoV nucleocapsid (N) protein was shown to inhibit the formation of SMAD3/4 complex, resulting in blocked TGFB-induced apoptosis and tissue fibrosis in SARS-CoVinfected host cells (Zhao et al., 2008) . In addition, most of the profibrotic activities was reported to cause by TGFB pathway modulation Fig. 3 . Predicted hairpin structures of SARS-CoV-2 encoded potential pre-miRNAs. The secondary and tertiary structures of each SARS-CoV-2 encoded pre-miRNAs are shown. While regions with pink color indicate the mature 5' miRNAs of each pre-miRNA, the green color indicate the mature 3' miRNAs of each pre-miRNA. Nucleotides shared between 5 ′ and 3 ′ mature miRNAs are represented in purple. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.) (Flanders, 2004) . SARS-CoV-2 has also been reported to cause lung fibrosis in some COVID-19 patients. Investigation on these miRNAs could help to understand mechanism of fibrosis caused by SARS-CoV-2 in COVID-19 patients.

Interleukins play essential roles in the activation and differentiation of immune cells, as well as proliferation, maturation, migration, and adhesion. They also have pro-inflammatory and anti-inflammatory properties (Akdis et al., 2016) . In our study IL2, IL5, IL7, IL8, IL10, IL13, IL15, IL16, IL17, IL21, IL22, IL24, IL25 and IL33 were targeted by SARS-CoV-2 miRNAs (Table 3) . It has been shown that interleukin levels change during COVID-19. By targeting these ILs, the virus may control systemic inflammation. IL10 and IL17 for example are critical cytokines to protect host from tissue damage and autoimmunity during acute phase of immune responses. Inhibition of these cytokines could cause excessive immune activation seen in COVID-19 (Conti et al., 2020; Ouyang et al., 2011; Veldhoen, 2017) . In addition, it has been reported that intensive care unit COVID-19 patients had higher plasma levels of IL2, IL7, IL10, suggesting a possible cytokine storm associated with these cytokines (Huang et al., 2020) .

Histone demethylases and histone deacetylates play important roles in epigenetic regulatory pathway of immune responses. In our study we found that JARID histone demethylase genes including JARID1A-JAR-ID1C and JARID2 and histone deacetylase genes including HDAC1-HDAC2-HDAC3 were targeted by SARS-CoV2 miRNAs (Table 3 ). It has previously been shown that JARID1 and JARID2 play regulatory role in human cytomegalovirus and Ebola virus infection. On the other hand, HDACs are involved in the regulation of the replication of numerous viruses (Bayarsaihan, 2011; Blair et al., 2011; Herbein and Wendling, 2010; Teng et al., 2015) .

It has been reported that cleavage of SARS coronavirus spike protein by protease TMPRSS11A enhances virus entry into human bronchial epithelial cells. It was also shown that it activates influenza A virus hemagglutinin and MERS coronavirus spike proteins (Kam et al., 2009; Zamora et al., 2017) . TMPRSS11A was also found to be targeted by SARS-CoV-2 miRNA in our study (Table 3) .

The infection with RNA viruses leads to the induction of signaling Our integrative network analysis carried out with all SARS-CoV-2 miRNA targeted genes identified with miRDB database showed that genes of central nervous system and genes involved in regulation of transcription are the most two groups of genes targeted by viral miRNAs (data not shown). It was recently documented that, in addition to systemic and respiratory symptoms, 36.4% of patients with COVID-19 develop neurological symptoms, including headache, disturbed consciousness, and paresthesia (Mao et al., 2020) .

40 SARS-CoV-2 miRNAs and their regulated targets were computationally predicted and reported. Our analysis showed that targeted genes play important roles in NFKB, JAK/STAT and TGFB signaling pathways, all of which have a great importance in different aspects of the host immune system. Some of these genes can be downregulated by miRNAs in order the virus to escape from immune system, some may be used to facilitate viral persistence within the cell. Following experimental validation and confirmation of our results, new therapeutic strategies could be developed to treat the COVID-19. Moreover, our results could help to understand virus-host interaction during SARS-CoV-2 infection.

Supplementary data to this article can be found online at https://doi. org/10.1016/j.genrep.2020.101012. 5 . Signaling pathway network analysis. SARS-CoV-2 miRNA targeted genes were filtered according to their roles in immune system and gene regulation network and analyzed with NetworkAnalyst program.

Cytotoxin and gene regulation associated genes targeted by SARS-CoV-2 encoded miRNAs.

Gene name SARS-CoV-2-miRNAs NFKB1 nuclear factor kappa B subunit 1 SARS-CoV-2-pre-miR-R2-3p, SARS-CoV-2-mir-D8-5p, SARS-CoV-2-mir-R1-5p NFKBIE NFKB inhibitor epsilon SARS-CoV-2-mir-D8-5p, SARS-CoV-2-mir-R1-5p, SARS-CoV-2-pre-miR-D10-3p, SARS-CoV-2-pre-miR-D10-3p, IKBKE inhibitor of nuclear factor kappa B kinase subunit epsilon SARS-CoV-2-mir-D2-3p, SARS-CoV-2-pre-miR-D2-5p CXCL9

C-X-C motif chemokine ligand 9 SARS-CoV-2-mir-R5-5p, SARS-CoV-2-mir-R5-3p, SARS-CoV-2-pre-miR-D9-3p, SARS-CoV-2-pre-miR-D1-5p, SARS-CoV-2-pre-miR-D1-5p CXCL1

C-X-C motif chemokine ligand 1 SARS-CoV-2-mir-R2-5p, SARS-CoV-2-pre-miR-R6-5p CXCL10

C-X-C motif chemokine ligand 10 SARS-CoV-2-mir-R1-3p,

Interferon gamma receptor 2 SARS-CoV-2-mir-D7-5p, SARS-CoV-2-mir-D14-5p SOCS1

Suppressor of cytokine signaling 1 SARS-CoV-2-mir-D6-3p, SARS-CoV-2-mir-D8-5p, SARS-CoV-2-mir-D10-5p SOCS3

Suppressor of cytokine signaling 3 SARS-CoV-2-mir-D5-3p, SARS-CoV-2-mir-D11-5p, SARS-CoV-2-mir-D14-3p SOCS4

Suppressor of cytokine signaling 4 SARS-CoV-2-mir-D6-3p SOCS5

Suppressor of cytokine signaling 5 SARS-CoV-2-mir-D8-5p, SARS-CoV-2-mir-D2-3p, SARS-CoV-2-mir-D14-5p, SARS-CoV-2-pre-miR-D9-3p SOCS6

Suppressor of cytokine signaling 6 SARS-CoV-2-mir-D6-5p, SARS-CoV-2-mir-R3-3p, SARS-CoV-2-mir-R5-5p, SARS-CoV-2-pre-miR-R1-3p STAT6

Signal transducer and activator of transcription 6 SARS-CoV-2-mir-D10-3p

Signal transducer and activator of transcription 4 SARS-CoV-2-mir-R2-5p

Signal transducer and activator of transcription 3 SARS-CoV-2-mir-D8-5p, SARS-CoV-2-mir-R2-5p, SARS-CoV-2-mir-R3-3p STAT5B

Signal transducer and activator of transcription 5B

SARS-CoV-2-mir-D1-5p, SARS-CoV-2-mir-D3-3p, SARS-CoV-2-mir-D6-5p, SARS-CoV-2-mir-R1-5p, SARS-CoV-2-pre-miR-D5-5p, SARS-CoV-2-pre-miR-D13-5p TGFBR1

Transforming growth factor beta receptor 1 SARS-CoV-2-mir-D9-5p, SARS-CoV-2-mir-D14-5p, SARS-CoV-2-mir-R2-5p, SARS-CoV-2-mir-R6-3p TGFBR2

Transforming growth factor beta receptor 2 SARS-CoV-2-mir-R3-3p, SARS-CoV-2-mir-R6-3p JAK1

Janus kinase 1 SARS-CoV-2-mir-R3-3p JAK2

Janus kinase 2 SARS-CoV-2-mir-D4-5p SMAD2 SMAD family member 2 SARS-CoV-2-mir-D8-3p, SARS-CoV-2-mir-R2-5p, SARS-CoV-2-mir-D3-5p, SARS-CoV-2-mir-R4-5p, SARS-CoV-2-mir-R1-5p, SARS-CoV-2-mir-R6-3p SMAD3 SMAD family member 3 SARS-CoV-2-mir-D10-5p, SARS-CoV-2-mir-R6-5p, SARS-CoV-2-mir-R4-3p SMAD4 SMAD family member 4 

There is no conflict of interest. Hypoxia inducible factor 1 subunit alpha SARS-CoV-2-mir-R5-5p, SARS-CoV-2-mir-D14-5p, SARS-CoV-2-mir-R2-5p, SARS-CoV-2-mir-R3-3p CTNNB1

Catenin beta 1 SARS-CoV-2-mir-D14-5p MAPK1

Mitogen-activated protein kinase 1 SARS-CoV-2-mir-D2-5p, SARS-CoV-2-mir-R2-3p, SARS-CoV-2-mir-R5-5p, SARS-CoV-2-mir-R6-3p, SARS-CoV-2-mir-R3-3p, SARS-CoV-2-mir-D8-5p, SARS-CoV-2-mir-R2-5p MAPK3

Mitogen-activated protein kinase 3 SARS-CoV-2-mir-R6-3p MAPK4

Mitogen-activated protein kinase 4 SARS-CoV-2-mir-D8-3p, SARS-CoV-2-mir-R3-3p, SARS-CoV-2-pre-miR-D11-5p MAPK6

Mitogen-activated protein kinase 6 SARS-CoV-2-mir-D4-5p, SARS-CoV-2-mir-R1-3p, SARS-CoV-2-mir-D6-3p, SARS-CoV-2-pre-miR-R2-3p MAPK7

Mitogen-activated protein kinase 7 SARS-CoV-2-mir-D6-3p NOS3

Nitric oxide synthase 3 SARS-CoV-2-mir-D6-3p PIK3CA

Phosphatidylinositol-4,5bisphosphate 3-kinase catalytic subunit alpha SARS-CoV-2-mir-D9-3p

Transmembrane serine protease 11A SARS-CoV-2-mir-D10-3p

Transmembrane serine protease 4 SARS-CoV-2-mir-D11-3p AKT1

AKT serine/threonine kinase 1 SARS-CoV-2-mir-D11-5p, SARS-CoV-2-mir-D6-3p, SARS-CoV-2-mir-R5-5p PTEN Phosphatase and tensin homolog SARS-CoV-2-mir-D8-3p, SARS-CoV-2-mir-D13-5p, SARS-CoV-2-mir-R1-3p, SARS-CoV-2-mir-D8-5p, SARS-CoV-2-mir-R6-3p, SARS-CoV-2-mir-R3-3p RB1

RB transcriptional corepressor 1 SARS-CoV-2-mir-R3-3p, SARS-CoV-2-pre-miR-D14-5p BCL2

BCL2 apoptosis regulator SARS-CoV-2-mir-R2-5p, SARS-CoV-2-mir-R6-3p, SARS-CoV-2-mir-D10-5p TNFRSF21 TNF receptor superfamily member 21 SARS-CoV-2-mir-R3-3p, SARS-CoV-2-mir-R2-3p

SARS-CoV-2-pre-miR-D2-5p, SARS-CoV-2-pre-miR-D2-3p, HDAC2 Histone deacetylase 2 SARS-CoV-2-mir-D10-5p, SARS-CoV-2-mir-D6-3p, HDAC3 Histone deacetylase 3 SARS-CoV-2-mir-R6-3p JARID1A Lysine demethylase 5A SARS-CoV-2-mir-D2-3p, SARS-CoV-2-mir-D2-5p, SARS-CoV-2-mir-D7-5p, SARS-CoV-2-mir-R1-5p, SARS-CoV-2-mir-R2-5p, SARS-CoV-2-mir-R6-3p JARID1C Lysine demethylase 5C SARS-CoV-2-mir-D12-5p, SARS-CoV-2-mir-D6-3p JARID2 Jumonji and AT-rich interaction domain containing 2 SARS-CoV-2-mir-D1-5p, SARS-CoV-2-mir-D6-3p

SARS-CoV-2-mir-D6-3p RHOA ras homolog family member A SARS-CoV-2-mir-D11-3p TBP TATA-box binding protein SARS-CoV-2-mir-R1-5p SP1 Sp1 transcription factor SARS-CoV-2-mir-D4-5p, SARS-CoV-2-mir-R6-3p, SARS-CoV-2-mir-D6-3p, SARS-CoV-2-mir-D10-3p, SARS-CoV-2-mir-D14-3p

Predicting effective microRNA target sites in mammalian mRNAs

Interleukins (from IL-1 to IL-38), interferons, transforming growth factor β, and TNF-α: Receptors, functions, and roles in diseases

Gene ontology: Tool for the unification of biology

Degradation of Host MicroRNAs by Poxvirus Poly(A) Polymerase Reveals Terminal RNA Methylation as a

MicroRNAs: target recognition and regulatory functions

Epigenetic mechanisms in inflammation

P bodies, stress granules, and viral life cycles

Cytokines induced during influenza virus infection

Epigenetic regulation by lysine demethylase 5 (KDM5) enzymes in cancer

MERS-CoV 4b protein interferes with the NF-κB-dependent innate immune response during infection

The Gene Ontology Resource: 20 years and still GOing strong

A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster

Danger, diversity and priming in innate antiviral immunity

Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies

VARNA: interactive drawing and editing of the RNA secondary structure

Virus evolution

MicroRNA targets in drosophila

The emerging role of microRNAs in Alzheimer's disease

Smad3 as a mediator of the fibrotic response

Viral inhibition of the IFN-induced JAK/STAT signalling pathway: development of live attenuated vaccines by mutation of viral-encoded IFNantagonists

Engineered herpes simplex viruses efficiently infect and kill CD133+ human glioma xenograft cells that express CD111

Type 1 Interferons and the virus-host relationship: a lesson in detente

Inhibitors of NF-κB signaling: 785 and counting

MatureBayes: a probabilistic algorithm for identifying the mature miRNA within novel precursors

miRBase: tools for microRNA genomics

A combined computational and microarray-based approach identifies novel microRNAs encoded by human gammaherpesviruses

The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak -an update on the status

MicroRNAs in human diseases: from Cancer to cardiovascular disease

The JAK/STAT pathway

Histone deacetylases in viral infections

The evolutionary genetics of emerging viruses

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

MicroRNA-like viral small RNA from dengue virus 2 autoregulates its replication in mosquito cells

West Nile virus encodes a microRNA-like small RNA in the 3 ′ untranslated region which up-regulates GATA4 mRNA and facilitates virus replication in mosquito cells

MiPred: classification of real and pseudo microRNA precursors using random forest prediction model with combined features

Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA

Cleavage of the SARS coronavirus spike glycoprotein by airway proteases enhances virus entry into human bronchial epithelial cells in vitro

KEGG: Kyoto encyclopedia of genes and genomes

The complex role of STAT3 in viral infections

The NS5 Protein of the Virulent West Nile Virus NY99 Strain Is a Potent Antagonist of Type I Interferon-Mediated JAK-STAT Signaling

Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia

Identification of Ebola virus microRNAs and their putative pathological function

Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding

Neurologic Manifestations of Hospitalized Patients with Coronavirus Disease

PANTHER version 14: more genomes, a new PANTHER GO-slim and improvements in enrichment analysis tools

SARS-CoV-encoded small RNAs contribute to infection-associated lung pathology

JAK and STAT signaling molecules in Immunoregulation and immune-mediated disease

Regulation and functions of the IL-10 family of cytokines in inflammation and disease

The V Protein of Human Parainfluenza Virus 2 Antagonizes Type I Interferon Responses by Destabilizing Signal Transducer and Activator of Transcription 2

RNA FRABASE 2.0: an advanced web-accessible database with the capacity to search the three-dimensional fragments within RNA structures

Ebola virus produces discrete small noncoding RNAs independently of the host MicroRNA pathway which lack RNA interference activity in bat and human cells

Circulating long non-coding RNAs in cancer: current status and future perspectives

Modulation of NF-κB signalling by microbial pathogens

JAK-STAT pathway targeting for the treatment of inflammatory bowel disease

NF-κB and virus infection: who controls whom

The intricate interplay between RNA viruses and NF-κB

Regulation of JAK-STAT signalling in the immune system

A determinant of Sindbis virus Neurovirulence enables efficient disruption of Jak/STAT signaling

Viruses, microRNAs, and host interactions

Induction of a Striking Systemic Cytokine Cascade prior to Peak Viremia in Acute Human Immunodeficiency Virus Type 1 Infection, in Contrast to More Modest and Delayed Responses in Acute Hepatitis B and C Virus Infections

A family of cytokine-inducible inhibitors of signalling

Vertebrate virus-encoded microRNAs and their sequence conservation

Systematic Genome-wide Screening and Prediction of microRNAs in EBOV During the

Brief review on COVID-19: the 2020 pandemic caused by SARS-CoV-2

Interleukin 17 is a chief orchestrator of immunity

NF-κB as a potential therapeutic target in microbial diseases

Detection of SARS-CoV-2 in different types of clinical specimens

miRDB: an online resource for microRNA target prediction and functional annotations

The SARS-CoV-2 outbreak: what we know

MicroRNA Control in the Immune

Licensing delineates helper and effector NK cell subsets during viral infection

Severe acute respiratory syndrome-associated coronavirus nucleocapsid protein interacts with Smad3 and modulates transforming growth factor-β signaling

NetworkAnalyst 3.0: a visual analytics platform for comprehensive gene expression profiling and meta-analysis

Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.